FDA
-
-
-
-
-
-
-
PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors
-
-
-
-
-
-
-
Medincell raises €48 million in private placement
-
-
-
-
-
-
-
Medincell’s ISS ESG Corporate Rating Upgraded
-
-
-
-
-
-
-
Medincell Management to Present at the 8th Annual Evercore Healthcare Conference and at the Piper Sandler 37th Annual Healthcare Conference
-
-
-
-
-
-
-
FDA approves UZEDY for bipolar I disorder maintenance treatment
-
-
-
-
-
-
-
Medincell: New Data Show that UZEDY® Initiation in Hospitalized Patients is Associated with Faster Discharge and an Overall Clinician Preference Compared to Invega Sustenna®
-
-
-
-
-
-
-
Medincell Announces the Availability of its 2024-25 Universal Registration Document including the Annual Financial and CSR Reports
-
322,972 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

